Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2017 / Cilt: 26 - Sayı: 3

Comparison of Different Dialysis Modalities in End-Stage Renal Disease Patients with Acute Dialysis Requirement

Acil Diyaliz Gereksinimi Olan Son Dönem Böbrek Yetmezlikli Hastalarda Farklı Diyaliz Yöntemlerinin Karşılaştırılması

Pages
298–304
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: Urgent PD could be an alternative modality in end-stage renal disease patients with acute dialysis requirement.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: There is little knowledge on the differences between PD or HD initiation in terms of early and late morbidity and other complications.
📊
Key Findings & Data:Group 1: The patients who had acute dialysis indication and started urgent PD (n=23), Group 2: The patients who had acute dialysis indication and started urgent HD (n=21), Group 3: The patients with no acute dialysis indication and started dialysis two weeks after PD catheter insertion (n=20).
💡
Conclusion & Impact:CONCLUSION: Urgent PD could be an alternative modality in end-stage renal disease patients with acute dialysis requirement.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: There is little knowledge on the differences between PD or HD initiation in terms of early and late morbidity and other complications. We aimed to compare the effect of different dialysis modalities on inflammation and other complications in a one-year prospective follow-up. MATERIAL and METHODS: The patients were divided into three groups depending on their dialysis requirements and compared in terms of inflammation and complications. Group 1: The patients who had acute dialysis indication and started urgent PD (n=23), Group 2: The patients who had acute dialysis indication and started urgent HD (n=21), Group 3: The patients with no acute dialysis indication and started dialysis two weeks after PD catheter insertion (n=20). RESULTS: HD patients had significantly lower urine levels and higher hemoglobin levels after 12 months in comparison with other groups. Complications of catheter-related infections were similar among the three groups, although catheter-related leaks were only found in the urgent PD group. There were no differences in terms of inflammatory markers among the groups. CONCLUSION: Urgent PD could be an alternative modality in end-stage renal disease patients with acute dialysis requirement.

Özet

AMAÇ: Farklı diyaliz modalitelerinin erken ve geç dönem morbiditesi ile birlikte inflamasyon, kateter ilişkili komplikasyon ve kalan böbrek işi gibi komplikasyonlar açısından farkları hakkında az miktarda bilgi mevcuttur. Bu yüzden, bir yıllık prospektif takip süresi olan bu çalışmada farklı diyaliz modalitelerinin inflamasyon ve diğer komplikasyonlar açısından farklarını incelemeyi hedefledik. GEREÇ ve YÖNTEMLER: Hastalar diyaliz gerekliliklerine göre üç gruba ayrılmış ve inflamasyon ve komplikasyonlar açısından karşılaştırılmıştır. Grup 1: akut diyaliz endikasyonu olan ve ivedi PD başlanan hastalar (n=23), Grup 2: akut diyaliz endikasyonu olan ve ivedi HD başlanan hastalar (n=21), Grup 3: akut diyaliz endikasyonu olmayan ve planlanmış PD başlanan hastalar (n=20). BULGULAR: HD hastaları 12. ayın sonunda diğer gruplarla karşılaştırıldığında anlamlı ölçüde düşük idrar volumü ve yüksek hemoglobin seviyesine sahipti. Kateter ilişkili enfeksiyon komplikasyonu açısından üç grupta benzerdi, buna rağmen kateter ilişkili kaçak sadece ivedi PD grubunda saptandı. İnflamatuvar göstergeler açısından her üç grup arasında fark yoktu. SONUÇ: İvedi PD'nin akut diyaliz endikasyonu olan hastalarda alternatif bir tedavi olabileceği düşünüldü.

🔖

Cite This Article

TOKGÖZ, B., SİPAHİOĞLU, M. H., YAZICI, C., EROĞLU, E., ÜNAL, A., OYMAK, O., KOÇYİĞİT, İ., DOĞAN, M., DOĞAN, İ. (2022). Comparison of Different Dialysis Modalities in End-Stage Renal Disease Patients with Acute Dialysis Requirement. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 26 - Sayı: 3, 298–304. https://ajindex.com/articles/636132

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI: KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 2014;63:713-735 2. Tokgoz B: Clinical advantages of peritoneal dialysis. Perit Dial Int 2009;29 Suppl 2:S59-61 3. Ivarsen P, Povlsen JV: Can peritoneal dialysis be applied for unplanned initiation of chronic dialysis? Nephrol Dial Transplant 2014;29:2201-2206 4. Oldani S, Finazzi S, Bottazzi B, Garlanda C, Baldassarre E, Valaperta S, Cuccovillo I, Albini M, Child M, Montanelli A, Graziani G, Badalamenti S: Plasma pentraxin-3 as a marker of bioincompatibility in hemodialysis patients. J Nephrol 2012;25:120- 126 5. Speeckaert MM, Speeckaert R, Carrero JJ, Vanholder R, Delanghe JR: Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease. J Clin Immunol 2013;33:881-890 6. Kocyigit I, Eroglu E, Orscelik O, Unal A, Gungor O, Ozturk F, Karakukcu, Imamoglu H, Sipahioglu MH, Tokgoz B, Oymak O: Pentraxin 3 as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease. J Nephrol 2014;27:181-186 7. Tong M, Carrero JJ, Qureshi AR, Anderstam B, Heimbürger O, Bárány P, Axelsson J, Alvestrand A, Stenvinkel P, Lindholm B, Suliman ME: Plasma pentraxin 3 in patients with chronic kidney disease: Associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. Clin J Am Soc Nephrol 2007;2:889-897 8. Suliman ME, Yilmaz MI, Carrero JJ, Qureshi AR, Saglam M, Ipcioglu OM, Yenicesu M, Tong M, Heimbürger O, Barany P, Alvestrand A, Lindholm B, Stenvinkel P: Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease. Clin J Am Soc Nephrol 2008;3:976-985 9. Hemodialysis Adequacy 2006 Work Group: Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 2006;48 Suppl 1:S2-90 10. Abecassis M, Bartlett ST, Collins AJ, Davis CL, Delmonico FL, Friedewald JJ, Hays R, Howard A, Jones E, Leichtman AB, Merion RM, Metzger RA, Pradel F, Schweitzer EJ, Velez RL, Gaston RS: Kidney transplantation as primary therapy for end-stage renal disease: A National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol 2008;3:471-480 11. Banli O, Altun H, Oztemel A: Early start of CAPD with the Seldinger technique. Perit Dial Int 2005;25:556-559 12. P